Literature DB >> 22431579

Endothelin 1 activation of endothelin A receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension.

Dan-Dan Chen1, Yu-Gang Dong, Hong Yuan, Alex F Chen.   

Abstract

Circulating endothelial progenitor cells (EPCs) are reduced in hypertension, which inversely correlates with its mortality. Deoxycorticosterone acetate (DOCA)-salt hypertension features elevated endothelin (ET) 1 and oxidative stress. We tested the hypothesis that ET-1 induces EPC dysfunction by elevating oxidative stress through the ET(A)/NADPH oxidase pathway in salt-sensitive hypertension. Both ET(A) and ET(B) receptors were expressed in EPCs, but only ET(A) receptors were significantly increased in EPCs of DOCA-salt rats. EPC number and function were reduced in DOCA-salt rats compared with sham controls, and both were reversed by in vivo blockade of ET(A) receptors or NADPH oxidase. The enzymatic activities of NAPDH oxidase and its subunits gp91(phox), p22(phox), and Rac1 were augmented in EPCs of DOCA-salt rats, with concomitantly decreased antioxidant enzymes manganese superoxide dismutase, copper-zinc superoxide dismutase, and glutathione peroxidase 1. Reactive oxygen species level was elevated in EPCs from DOCA-salt rats, accompanied by increased EPC telomerase inactivation, senescence, and apoptosis, which were rescued by ET(A) or NADPH oxidase blockade. Cell therapy of normal or treated DOCA EPCs, but not untreated DOCA EPCs, significantly increased capillary density and blood perfusion in ischemic hindlimbs of DOCA-salt rats. p53 and Bax/Bcl-2 ratios were increased in EPCs of DOCA-salt rats, which were reversed by ET(A) antagonist, NADPH oxidase inhibitor, or polyethylene glycol-superoxide dismutase. Finally, in ET(B)-deficient rats, plasma ET-1 was elevated, and EPC number and telomerase activity were diminished. These results demonstrate, for the first time, that both ET-1 activation of ET(A)/NADPH oxidase pathway and diminished antioxidants critically contribute to EPC reduction and dysfunction via increased oxidative stress in salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431579      PMCID: PMC5008242          DOI: 10.1161/HYPERTENSIONAHA.111.183368

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Salt-sensitive hypertension in endothelin-B receptor-deficient rats.

Authors:  C E Gariepy; T Ohuchi; S C Williams; J A Richardson; M Yanagisawa
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension.

Authors:  Toshio Imanishi; Chizu Moriwaki; Takuzo Hano; Ichiro Nishio
Journal:  J Hypertens       Date:  2005-10       Impact factor: 4.844

Review 3.  Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.

Authors:  Victor J Dzau; Massimiliano Gnecchi; Alok S Pachori; Fulvio Morello; Luis G Melo
Journal:  Hypertension       Date:  2005-06-13       Impact factor: 10.190

Review 4.  Vascular endothelin in hypertension.

Authors:  Ernesto L Schiffrin
Journal:  Vascul Pharmacol       Date:  2005-06       Impact factor: 5.773

Review 5.  Endothelial progenitor cells in cardiovascular disorders.

Authors:  Eduard Shantsila; Timothy Watson; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2007-02-20       Impact factor: 24.094

6.  Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats.

Authors:  J Fareh; R M Touyz; E L Schiffrin; G Thibault
Journal:  J Mol Cell Cardiol       Date:  2000-04       Impact factor: 5.000

7.  Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.

Authors:  Lixin Li; Gregory D Fink; Stephanie W Watts; Carrie A Northcott; James J Galligan; Patrick J Pagano; Alex F Chen
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

8.  Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress.

Authors:  Toshio Imanishi; Takuzo Hano; Ichiro Nishio
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

9.  Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension.

Authors:  Lixin Li; Yi Chu; Gregory D Fink; John F Engelhardt; Donald D Heistad; Alex F Chen
Journal:  Hypertension       Date:  2003-09-29       Impact factor: 10.190

10.  GTP cyclohydrolase I/BH4 pathway protects EPCs via suppressing oxidative stress and thrombospondin-1 in salt-sensitive hypertension.

Authors:  He-Hui Xie; Shuang Zhou; Dan-Dan Chen; Keith M Channon; Ding-Feng Su; Alex F Chen
Journal:  Hypertension       Date:  2010-11-08       Impact factor: 10.190

View more
  24 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 2.  Management of VEGF-Targeted Therapy-Induced Hypertension.

Authors:  Stefano Caletti; Anna Paini; Maria Antonietta Coschignano; Carolina De Ciuceis; Matteo Nardin; Roberto Zulli; Maria Lorenza Muiesan; Massimo Salvetti; Damiano Rizzoni
Journal:  Curr Hypertens Rep       Date:  2018-06-29       Impact factor: 5.369

3.  Preserved function of late-outgrowth endothelial cells in medically treated hypertensive patients under well-controlled conditions.

Authors:  Zhi Chen; Sandra M S Herrmann; Xiangyang Zhu; Kyra L Jordan; Monika L Gloviczki; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2014-07-21       Impact factor: 10.190

4.  Bone marrow transplantation improves endothelial function in hypertensive Dahl salt-sensitive rats.

Authors:  Hong Yu; Hongwei Shao; Jing Yan; Nikolaos M Tsoukias; Ming-Sheng Zhou
Journal:  J Am Soc Hypertens       Date:  2012 Sep-Oct

5.  NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Authors:  Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

6.  Ovarian hormones modulate endothelin A and B receptor expression.

Authors:  Eman Y Gohar; Choudhury Yusuf; David M Pollock
Journal:  Life Sci       Date:  2016-01-08       Impact factor: 5.037

Review 7.  Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2013-06-06       Impact factor: 8.401

Review 8.  Endothelin, kidney disease, and hypertension.

Authors:  Joshua S Speed; David M Pollock
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

Review 9.  Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.

Authors:  Eman Y Gohar; Fernanda R Giachini; David M Pollock; Rita C Tostes
Journal:  Life Sci       Date:  2016-03-03       Impact factor: 5.037

10.  Mechanisms of NFATc3 activation by increased superoxide and reduced hydrogen peroxide in pulmonary arterial smooth muscle.

Authors:  Juan Manuel Ramiro-Diaz; Wieslawa Giermakowska; John M Weaver; Nikki L Jernigan; Laura V Gonzalez Bosc
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-27       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.